Abstract:1368 Therapeutic selectivity is important for anticancer drug development. Understanding the biological differences between normal and cancer cells is essential in designing strategies to preferentially kill cancer cells. Compared to normal cells, most cancer cells exhibit high metabolic activity, generate increased levels of reactive oxygen species (ROS), and are under oxidative stress. Elevated ROS renders the cancer cells more vulnerable to further ROS stress by exogenous ROS-generating agents. Here, we report that immortalization of ovarian epithelial cells with SV40 and hTERT followed by transformation with H-RasV12 oncogene rendered the cells tumorigenic, and exhibited significantly higher ROS generation compared to the non-tumorigenic parental cells. The malignant cells were highly vulnerable to further oxidative stress by β-phenylethyl isothiocyanates (PEITC), a dietary metabolic product of cruciferous vegetables. Treatment with 10 μM PEITC for 5 h preferentially induced ROS generation in (15-19 fold increase) and induced massive cell death (60-80%) within a relatively short period (5-24 h). In contrast, the parental non-tumorigenic cells without ras-transformation exhibited low basal ROS generation and better tolerated PEITC-induced ROS stress, as evidenced by only a modest ROS increase and less cell death (10-20%, 10 μM, 5-24 h). The in vitro therapeutic selectivity of PEITC against ovarian cancer cells was superior to cisplatin. Further studies revealed that PEITC caused a more severe depletion of glutathione in the malignant cells (93%, 5 μM, 3h) compared to the non-tumorigenic cells (52%), which appeared to be a biochemical mechanism for preferential increase of ROS in the malignant cells. Mechanistic studies demonstrated that PEITC induced cell death by causing a striking ROS-mediated oxidative damage to the mitochondrial membranes, and disrupting the redox-sensitive survival pathways such as NF-KB and Ras in the cancer cells. The action of PEITC was reversed by antioxidant N-acetylcysteine and ROS scavenger enzyme catalase. The promising therapeutic activity of PEITC was further demonstrated in animal models bearing the ras-transformed ovarian cancer cells, with an 84% increase in median animal survival time (25 vs 48 days, p

MiR-135a and MRP1 Play Pivotal Roles in the Selective Lethality of Phenethyl Isothiocyanate to Malignant Glioma Cells.

PEITC induces apoptosis of Human Brain Glioblastoma GBM8401 Cells through the extrinsic- and intrinsic -signaling pathways

PEITC inhibits human brain glioblastoma GBM 8401 cell migration and invasion through the inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and -9 gene expression

Phenethyl Isothiocyanate Inhibits in Vivo Growth of Xenograft Tumors of Human Glioblastoma Cells

Phenethyl Isothiocyanate Triggers Apoptosis in Human Malignant Melanoma A375.S2 Cells Through Reactive Oxygen Species and the Mitochondria-Dependent Pathways.

Phenethyl isothiocyanate alters the gene expression and the levels of protein associated with cell cycle regulation in human glioblastoma GBM 8401 cells

Selective Killing of Oncogenic Transformed Cells Through ROS-mediated Mechanism by Β-Phenylethyl Isothiocyanates

Phenethyl Isothiocyanate (PEITC) Promotes G2/M Phase Arrest Via P53 Expression and Induces Apoptosis Through Caspase- and Mitochondria-Dependent Signaling Pathways in Human Prostate Cancer DU 145 Cells.

Effective Killing of CML Cells by PEITC is Associated with Rapid Increase of Cellular ROS, Depletion of Glutathione and BCR-ABL Degradation

MiR-135a functions as a selective killer of malignant glioma

Mirna-214 Inhibits Cellular Proliferation and Migration in Glioma Cells Targeting Caspase 1 Involved in Pyroptosis.

Benzyl Isothiocyanate Induces Apoptotic Cell Death Through Mitochondria-dependent Pathway in Gefitinib-resistant NCI-H460 Human Lung Cancer Cells in Vitro

PEITC triggers multiple forms of cell death by GSH-iron-ROS regulation in K7M2 murine osteosarcoma cells

Peneciraistin C Induces Caspase-Independent Autophagic Cell Death Through Mitochondrial-Derived Reactive Oxygen Species Production in Lung Cancer Cells

Phenethyl isothiocyanate induced apoptosis via down regulation of Bcl-2/XIAP and triggering of the mitochondrial pathway in MCF-7 cells

Phenylethyl isothiocyanate reverses cisplatin resistance in biliary tract cancer cells via glutathionylation-dependent degradation of Mcl-1

Phenethyl Isothiocyanate Inhibited Tumor Migration and Invasion Via Suppressing Multiple Signal Transduction Pathways in Human Colon Cancer HT29 Cells.

PD-L1 Inhibitor Regulates the miR-33a-5p/PTEN Signaling Pathway and Can Be Targeted to Sensitize Glioblastomas to Radiation

A miR-137-XIAP axis contributes to the sensitivity of TRAIL-induced cell death in glioblastoma

Phenethyl Isothiocyanate (PEITC) Inhibits the Growth of Human Oral Squamous Carcinoma HSC-3 Cells Throughg0/g1phase Arrest and Mitochondria-Mediated Apoptotic Cell Death

Phenethyl Isothiocyanate Inhibits Migration and Invasion of Human Gastric Cancer AGS Cells Through Suppressing MAPK and NF-kappaB Signal Pathways.